These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 27884167)

  • 1. Rett syndrome - biological pathways leading from MECP2 to disorder phenotypes.
    Ehrhart F; Coort SL; Cirillo E; Smeets E; Evelo CT; Curfs LM
    Orphanet J Rare Dis; 2016 Nov; 11(1):158. PubMed ID: 27884167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
    Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
    Yang W; Pan H
    Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
    Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
    Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective preservation of cholinergic MeCP2 rescues specific Rett-syndrome-like phenotypes in MeCP2
    Zhou H; Wu W; Zhang Y; He H; Yuan Z; Zhu Z; Zhao Z
    Behav Brain Res; 2017 Mar; 322(Pt A):51-59. PubMed ID: 28093257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease.
    Pejhan S; Rastegar M
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33429932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Alpha-Synuclein Gene (SNCA) is a Genomic Target of Methyl-CpG Binding Protein 2 (MeCP2)-Implications for Parkinson's Disease and Rett Syndrome.
    Schmitt I; Evert BO; Sharma A; Khazneh H; Murgatroyd C; Wüllner U
    Mol Neurobiol; 2024 Oct; 61(10):7830-7844. PubMed ID: 38429622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rett syndrome and the urge of novel approaches to study MeCP2 functions and mechanisms of action.
    Bedogni F; Rossi RL; Galli F; Cobolli Gigli C; Gandaglia A; Kilstrup-Nielsen C; Landsberger N
    Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():187-201. PubMed ID: 24594195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
    Gadalla KK; Bailey ME; Cobb SR
    Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MeCP2 dysfunction in Rett syndrome and related disorders.
    Moretti P; Zoghbi HY
    Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic and Epigenomic Landscape in Rett Syndrome.
    Marano D; Fioriniello S; D'Esposito M; Della Ragione F
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis of variable phenotypic severity among common missense mutations causing Rett syndrome.
    Brown K; Selfridge J; Lagger S; Connelly J; De Sousa D; Kerr A; Webb S; Guy J; Merusi C; Koerner MV; Bird A
    Hum Mol Genet; 2016 Feb; 25(3):558-70. PubMed ID: 26647311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating Rett syndrome: from mouse models to human therapies.
    Vashi N; Justice MJ
    Mamm Genome; 2019 Jun; 30(5-6):90-110. PubMed ID: 30820643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and analysis of the Rett syndrome-associated MeCP2- null rat model.
    Zhai W; Hu HX; Le L; Zhuang FF; Wang KZ; Zhao Y; Wang K; Liu XM; Sun D; Wang XY; Kuang SH; Hu KP
    Yi Chuan; 2016 Nov; 38(11):1004-1011. PubMed ID: 27867150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes.
    Tsujimura K; Irie K; Nakashima H; Egashira Y; Fukao Y; Fujiwara M; Itoh M; Uesaka M; Imamura T; Nakahata Y; Yamashita Y; Abe T; Takamori S; Nakashima K
    Cell Rep; 2015 Sep; 12(11):1887-901. PubMed ID: 26344767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Landscape of Rett Syndrome Spectrum: Improvements and Challenges.
    Vidal S; Xiol C; Pascual-Alonso A; O'Callaghan M; Pineda M; Armstrong J
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31409060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal non-CG methylation is an essential target for MeCP2 function.
    Tillotson R; Cholewa-Waclaw J; Chhatbar K; Connelly JC; Kirschner SA; Webb S; Koerner MV; Selfridge J; Kelly DA; De Sousa D; Brown K; Lyst MJ; Kriaucionis S; Bird A
    Mol Cell; 2021 Mar; 81(6):1260-1275.e12. PubMed ID: 33561390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MECP2 disorders: from the clinic to mice and back.
    Lombardi LM; Baker SA; Zoghbi HY
    J Clin Invest; 2015 Aug; 125(8):2914-23. PubMed ID: 26237041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MeCP2 Deficiency Leads to Loss of Glial Kir4.1.
    Kahanovitch U; Cuddapah VA; Pacheco NL; Holt LM; Mulkey DK; Percy AK; Olsen ML
    eNeuro; 2018; 5(1):. PubMed ID: 29464197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rett syndrome: from the gene to the disease.
    Matijevic T; Knezevic J; Slavica M; Pavelic J
    Eur Neurol; 2009; 61(1):3-10. PubMed ID: 18948693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.